Talphera (TLPH) Return on Capital Employed Growth (1y) (2013 - 2026)
Talphera (TLPH) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 696.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -494.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 89.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 448.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1,397.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -1,715.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,309.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 999.00 |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | 4,130.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,130.00 |
| Sep 30, 2025 | 1,818.00 |
| Jun 30, 2025 | -3,335.00 |
| Mar 31, 2025 | -2,086.00 |
| Dec 31, 2024 | 770.00 |
| Sep 30, 2024 | -18,151.00 |
| Jun 30, 2024 | -15,623.00 |
| Mar 31, 2024 | -10,953.00 |
| Dec 31, 2023 | -12,693.00 |
| Sep 30, 2023 | 9,678.00 |
| Jun 30, 2023 | 9,453.00 |
| Mar 31, 2023 | 4,061.00 |
| Dec 31, 2022 | 4,242.00 |
| Sep 30, 2022 | 1,049.00 |
| Jun 30, 2022 | 57.00 |
| Mar 31, 2022 | -256.00 |
| Dec 31, 2021 | 443.00 |
| Sep 30, 2021 | 8,525.00 |
| Jun 30, 2021 | 8,428.00 |
| Mar 31, 2021 | 8,122.00 |